From AI to Amgen, Here’s Everything IP that Mattered in 2023
From AI to Amgen, Here’s Everything IP that Mattered in 2023 Read More »
WASHINGTON (December 8, 2023) — Today, C4IP Board Members and former Federal Circuit Court Judges Kathleen O’Malley and Paul Michel issued the following statement on the Biden administration’s decision to claim a newfound authority, under the 43-year-old Bayh-Dole Act, to rescind patent licenses on drugs, energy, climate change, and all other inventions that benefit from
WASHINGTON (December 5, 2023) — Yesterday, the Council for Innovation Promotion (C4IP) and nearly 50 former government officials and intellectual property experts sent a letter to President Biden urging his administration to oppose a proposal before the World Trade Organization to waive intellectual property rights for Covid-19 therapeutics and diagnostics. Notable letter signatories include former
Council for Innovation Promotion Urges Biden Admin to Oppose IP Waiver Read More »